骨膜炎
川地34
祖细胞
转分化
肌成纤维细胞
癌症研究
干细胞
医学
骨髓
细胞生物学
病理
生物
血管生成
祖细胞
间质细胞
纤维细胞
间质细胞
免疫学
PI3K/AKT/mTOR通路
造血
内皮祖细胞
重编程
伤口愈合
主动脉瓣
下调和上调
再生医学
硬皮病(真菌)
作者
Xiaoping Yang,Hong Wu,Guoqiang Ren,Yuesheng Zhang,Zuoshi Wen,Pengwei Zhu,Zhangquan Ying,Liujun Jiang,Tingting Tao,Bohuan Zhang,Linwen Zhu,Han Wang,Han Zhang,Qingbo Xu,Jun Cheng,Honghua Ye
摘要
ABSTRACT Aortic valve sclerosis (AVS), characterised by fibrocalcific remodelling without significant hemodynamic obstruction, represents a critical window for early clinical intervention; however, its underlying cellular drivers during ageing remain poorly understood. Here, genetic lineage tracing and single‐cell RNA sequencing (scRNA‐seq) techniques were used to examine the temporal and spatial functions of CD34 + valvular interstitial cells (VICs) in ageing‐associated AVS. Human scRNA‐seq datasets were used in combination with natural ageing and D‐galactose (D‐gal)‐induced mouse models, and a significant age‐dependent downregulation of CD34 in VICs was identified. Lineage tracing and bone marrow (BM) chimeras confirmed that non‐BM CD34 + progenitor VICs (prog‐VICs), rather than bone marrow‐derived cells, serve as the origin of periostin + myofibroblast‐like VICs (myo‐VICs) during ageing. Functionally, the systemic or non‐BM‐specific ablation of CD34 + cells or the CD34 + Periostin + transitional subpopulation markedly attenuated age‐related leaflet thickening and fibrotic remodelling. Mechanistically, the JNK–JUNB signalling pathway, mediated by PDGFR, was found to be crucial for the pathological transdifferentiation of CD34 + prog‐VICs into periostin + myo‐VICs. Non‐BM CD34 + prog‐VICs were found to aggravate senescence‐associated AVS; thus, targeting the PDGFR–JNK–JUNB axis or preserving the prog‐VIC identity may offer therapeutic avenues to arrest early calcific aortic valve disease (CAVD) progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI